Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-α/β, IFN-γ, and IFN-λ in host defense

Interferon (IFN) was originally identified as a substance 'interfering' with viral replication in vitro. The first IFNs to be identified were classified as type I IFNs (IFN-α/β and related molecules), two other types have since been identified: type II IFN (IFN-γ) and type III IFNs (IFN-λ)...

Full description

Saved in:
Bibliographic Details
Published in:Immunological reviews 2008-12, Vol.226 (1), p.29-40
Main Authors: Zhang, Shen-Ying, Boisson-Dupuis, Stéphanie, Chapgier, Ariane, Yang, Kun, Bustamante, Jacinta, Puel, Anne, Picard, Capucine, Abel, Laurent, Jouanguy, Emmanuelle, Casanova, Jean-Laurent
Format: Article
Language:English
Subjects:
Animals
Cytokines - genetics
Cytokines - immunology
Genetic Predisposition to Disease
Humans
immunodeficiency
immunosuppression (physiological)
Infection - genetics
Infection - immunology
Infection - microbiology
Infection - virology
infectious disease
infectious diseases
interferon
Interferon-alpha - genetics
Interferon-alpha - immunology
Interferon-beta - genetics
Interferon-beta - immunology
Interferon-gamma - genetics
Interferon-gamma - immunology
interferons
Interferons - genetics
Interferons - immunology
Mice
Mycobacterium
Mycobacterium Infections - genetics
Mycobacterium Infections - immunology
Virus Diseases - genetics
Virus Diseases - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Interferon (IFN) was originally identified as a substance 'interfering' with viral replication in vitro. The first IFNs to be identified were classified as type I IFNs (IFN-α/β and related molecules), two other types have since been identified: type II IFN (IFN-γ) and type III IFNs (IFN-λ). Each IFN binds to one of three type-specific receptors. In the mouse model of experimental infections in vivo, IFN-α/β are essential for immunity to most viruses tested, whereas IFN-γ is important for immunity to a smaller number of viruses, together with bacteria, fungi, and parasites, consistent with IFN-γ acting as the 'macrophage activating factor.' The precise role of IFN-λ remains unclear. In recent years, inborn errors affecting the production of, or the response to, IFNs have been reported in human patients, shedding light onto the function of IFNs in natura. Disorders of IFN-γ production, caused by IL12B, IL12RB1, and specific NEMO mutations, or of IFN-γ responses, caused by IFNGR1, IFNGR2, and dominant STAT1 mutations, confer predisposition to mycobacterial disease in patients resistant to most viruses. By contrast, disorders of IFN-α/β and IFN-λ production, caused by UNC93B1 and TLR3 mutations, confer predisposition to herpes simplex encephalitis (HSE) in otherwise healthy patients. Consistently, patients with impaired responses to IFN-α/β, IFN-γ, and presumably IFN-λ (carrying recessive mutations in STAT1), or with impaired responses to IFN-α/β and impaired IFN-γ production (carrying mutations in TYK2), or with impaired production of IFN-α/β, IFN-γ, and IFN-λ (carrying specific mutations in NEMO), are vulnerable to mycobacterial and viral infections, including HSE. These experiments of nature suggest that the three types of IFNs play at least two different roles in host defense. IFN-γ is essential for anti-mycobacterial immunity, whereas IFN-α/β and IFN-λ are essential for anti-viral immunity. Future studies in humans aim to define the specific roles of IFN-α/β and IFN-λ types and individual molecules in host defense in natura.
ISSN:0105-2896
1600-065X
DOI:10.1111/j.1600-065X.2008.00698.x